Menu
The U.S. 2nd Circuit Court of Appeals' 3-0 decision reversed a lower court’s 2024 ruling that had denied health centers' antitrust claims against four drug manufacturers that have placed contract pharmacy restrictions.

In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

Shannon Young, Associate Editor/Senior Writer 340B Report Views
A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

HHS Touts 340B Rebate Pilot Proposal to Appeals Court, Hospitals File Amicus Brief Urging Court to Reject Rebates

HRSA Proposes Changes to STD Clinics and Other 340B Covered Entities’ Recertification and Enrollment Requirements; Extends Date for Rebate Comments

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Quick verification required before signup

Site Footer Live